WHO Nod To India’s Regulatory System A Booster For Vaccine Makers
This article was originally published in PharmAsia News
Indian vaccine makers see the latest move to qualify the Indian regulatory system as an opportunity to pump up exports.
You may also be interested in...
WHO Delists Panacea Biotec's Combination Vaccines From Pre-qualified List; Move Comes A Year After Action Against Sanofi's Shantha Unit
WHO Does What It Warned: Delists Shantha Biotech's Pentavalent Vaccine Shan5; More Pains For Sanofi-Aventis?
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.